Skip to content

Preliminary clinical study of capsule endoscopy AKEM-31SW/AKES-31SW

Preliminary clinical study of capsule endoscopy AKEM-31SW/AKES-31SW

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042427
Enrollment
Unknown
Registered
2021-01-21
Start date
2021-02-15
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Examination of stomach and / or small intestine diseases

Interventions

AKES-31SW group:AKES-31SW capsule endoscopy check up
GIVEN group:GIVEN capsule endoscopy check up
AKEM-11SW group:AKEM-11SW capsule endoscopy check up

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The first part (accepting AKES-31SW examination) 1) Male or female, aged >= 18 years; 2) The patients who are going to have small intestine capsule endoscopy, whether they have digestive system discomfort or not; 3) They agreed to participate in the clinical trial and signed the informed consent. The second part (accepting the AKEM-31SW examination): 1) Male or female, aged >= 18 years; 2) The patients who completed the magnetic capsule gastroscopy, no matter whether they had digestive system discomfort or not; 3) They agreed to participate in the clinical trial and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients who have participated in other clinical trials or are participating in other clinical trials within three months; 2) Those who have no surgical conditions or refuse to accept any abdominal surgery (once the capsule is retained, it will not be removed by surgery); 3) Cardiac pacemaker is installed in the body, except that the pacemaker is a new MRI compatible product; 4) Cochlear implant, magnetic metal drug infusion pump, nerve stimulator and other electronic devices and magnetic metal foreign bodies were implanted in vivo; 5) MRI examination was planned before capsule endoscopy was discharged; 6) Gastrointestinal obstruction, stenosis, diverticulum, fistula or active massive hemorrhage are known or suspected; 7) Previous abdominal operation history affecting normal structure of digestive tract; 8) Pregnant women; 9) Patients with mental illness; 10) Severe asthma, dysphagia, gastroparesis and other emptying disorders; 11) The general condition was poor, and could not tolerate MCE examination; 12) The researchers believe that there are any other factors that are not suitable for subjects to participate in the study.

Design outcomes

Primary

MeasureTime frame
The completeness of GI tract examination;Incidence of adverse events;

Secondary

MeasureTime frame
Comfort of swallowing capsule;Manipulation performance of capsule endoscopy;Check the relevant time indicators;Image quality;Disease detection rate;Lighting flash time range;Overall comfort of the subjects;

Countries

China

Contacts

Public ContactXiaohua Hou

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

houxh@hust.edu.cn+86 27-85726057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026